1. Home
  2. CUE vs ESP Comparison

CUE vs ESP Comparison

Compare CUE & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • ESP
  • Stock Information
  • Founded
  • CUE 2014
  • ESP 1928
  • Country
  • CUE United States
  • ESP United States
  • Employees
  • CUE N/A
  • ESP N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • ESP Industrial Machinery/Components
  • Sector
  • CUE Health Care
  • ESP Technology
  • Exchange
  • CUE Nasdaq
  • ESP Nasdaq
  • Market Cap
  • CUE 59.5M
  • ESP 148.8M
  • IPO Year
  • CUE 2018
  • ESP N/A
  • Fundamental
  • Price
  • CUE $0.73
  • ESP $44.47
  • Analyst Decision
  • CUE Strong Buy
  • ESP
  • Analyst Count
  • CUE 2
  • ESP 0
  • Target Price
  • CUE $3.00
  • ESP N/A
  • AVG Volume (30 Days)
  • CUE 132.9K
  • ESP 34.1K
  • Earning Date
  • CUE 11-13-2025
  • ESP 09-16-2025
  • Dividend Yield
  • CUE N/A
  • ESP 2.27%
  • EPS Growth
  • CUE N/A
  • ESP 31.88
  • EPS
  • CUE N/A
  • ESP 3.02
  • Revenue
  • CUE $8,286,000.00
  • ESP $43,950,872.00
  • Revenue This Year
  • CUE N/A
  • ESP N/A
  • Revenue Next Year
  • CUE $13.27
  • ESP N/A
  • P/E Ratio
  • CUE N/A
  • ESP $15.00
  • Revenue Growth
  • CUE N/A
  • ESP 13.46
  • 52 Week Low
  • CUE $0.45
  • ESP $22.50
  • 52 Week High
  • CUE $1.99
  • ESP $55.00
  • Technical
  • Relative Strength Index (RSI)
  • CUE 37.43
  • ESP 41.06
  • Support Level
  • CUE $0.71
  • ESP $46.00
  • Resistance Level
  • CUE $0.78
  • ESP $55.00
  • Average True Range (ATR)
  • CUE 0.03
  • ESP 2.70
  • MACD
  • CUE -0.01
  • ESP -0.33
  • Stochastic Oscillator
  • CUE 20.10
  • ESP 17.28

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About ESP Espey Mfg. & Electronics Corp.

Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.

Share on Social Networks: